ctrl K

Opus Genetics Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

0.94

-0.01 (-1.05%)

At close: May 01, 2025, 3:59 PM

0.92

-1.92%

Pre-market: May 02, 2025, 08:00 AM EDT

Opus Genetics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	10.99M	19.05M	39.85M	589K	n/a	n/a
Cost of Revenue	10K	n/a	n/a	n/a	n/a	n/a
Gross Profit	10.98M	19.05M	39.85M	589K	n/a	n/a
Operating Income	-62.07M	-10.56M	18.23M	-22.7M	-19.97M	-4.19M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-57.53M	-9.97M	18.2M	-56.69M	-24.62M	-6.17M
Net Income	-57.53M	-9.99M	17.89M	-56.69M	-24.62M	-6.17M
Selling & General & Admin	18.21M	11.96M	7.27M	8.12M	2.82M	1.82M
Research & Development	26.85M	17.65M	14.36M	15.17M	6.65M	2.37M
Other Expenses	28M	n/a	n/a	n/a	10.5M	n/a
Operating Expenses	73.07M	29.61M	21.62M	23.29M	19.97M	4.19M
Interest Expense	n/a	n/a	9K	2K	6.85M	1.41M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	73.07M	29.61M	21.62M	23.29M	19.97M	4.19M
Income Tax Expense	n/a	12K	315K	n/a	n/a	n/a
Shares Outstanding (Basic)	26.72M	21.59M	19.93M	14.85M	4.66M	7.09M
Shares Outstanding (Diluted)	26.72M	21.59M	20.6M	14.85M	4.66M	7.09M
EPS (Basic)	-2.15	-0.46	0.90	-3.82	-5.28	-0.87
EPS (Diluted)	-2.15	-0.46	0.87	-3.82	-5.28	-0.87
EBITDA	-57.52M	-9.97M	18.22M	-56.69M	-17.77M	-4.76M
EBIT	-57.53M	-9.97M	18.21M	-56.69M	-17.77M	-4.76M
Depreciation & Amortization	10K	6K	4K	4K	8K	3K